Australia’s GBMA Sharpens Biosimilars Focus With Celltrion

Celltrion has become the first company to join the new ‘biosimilar membership’ of Australia’s GBMA off-patent industry association, as the body sharpens its focus on biosimilars following a series of regulatory and other developments to bolster the market.